Pharmaceutical supply chain in China: Current issues and implications for health system reform

Health Policy

Volumn 97, Issue 1, 2010, Pages 8-15

  Yu, Xuan ^a,b   Li, Cheng ^a   Shi, Yuhua ^b   Yu, Min ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

China; Health care reform; Pharmaceutical market

Indexed keywords

CHINA; COST BENEFIT ANALYSIS; DISEASE COURSE; DRUG COST; DRUG DISTRIBUTION; DRUG FORMULARY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG PACKAGING; ECONOMIC ASPECT; ECONOMIC EVALUATION; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOSPITAL PURCHASING; INTERNET; LITERATURE; PUBLIC HEALTH; REGISTRATION; REVIEW; DRUG LEGISLATION; ECONOMICS; HEALTH CARE POLICY; HUMAN; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT; PUBLICATION; STANDARDS; SUPPLY AND DISTRIBUTION;

DRUG;

CHINA; DRUG COSTS; DRUG INDUSTRY; FORMULARIES AS TOPIC; HEALTH CARE REFORM; HUMANS; INSURANCE, HEALTH; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS;

EID: 77955088248     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2010.02.010     Document Type: Review

References (34)

1. Garattini L., Cornago D., De Compadri P. Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis. Health Policy 2007, 82:330-339.
2. Håkonsen H., Horn A.M., Toverud E.-L. Price control as a strategy for pharmaceutical cost containment-what has been achieved in Norway in the period 1994-2004?. Health Policy 2009, 90:277-285.
3. Wang L., Kong L., Wu F., Bai Y., Burton R. Preventing chronic diseases in China. The Lancet 2005, 366:1821-1824.
4. He J., Gu D., Wu X., Reynolds K., et al. Major causes of death among men and women in China. The New England Journal of Medicine 2005, 353:1124-1134.
5. Hu Y., Carolina O.L.U., Bian Y., Wang Y. Marketing strategy; the Chinese pharmaceutical market: dynamics and a proposed investment strategy. Journal of Medical Marketing 2007, 7:18-24.
6. Ministry of Health Yearbook of Chinese health statistics 2008, [in Chinese], [accessed 01/15/10]. http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2008/1.htm.
7. World Health Organization World Health Report 2000: health systems, improving performance 2000, World Health Organization, Geneva.
8. Hsiao W.C. The political economy of Chinese health system reform. Health Economics, Policy and Law 2007, 2:241-249.
9. Gerald B., Gu X.Y. Health sector reform: lessons from China. Social Science & Medicine 1997, 3:351-360.
10. World Bank Financing health care: issues and options for China 1997, World Bank, Washington, DC.
11. Hu S., Tang S., Liu Y., Zhao Y., Escobar M.-L., de Ferranti D. Reform of how health care is paid for in China: challenges and opportunities. Lancet 2008, 9652:1846-1853.
12. World Health Organization World Health Report 2002: reducing risk, promoting healthy life 2002, World Health Organization, Geneva.
13. Yip W., Hsiao W.C. MARKETWATCH: the Chinese health system at a crossroads. Health Affairs 2008, 27:460-468.
14. Dong H., Bogg L., Wang K., Rehnberg C., Diwan V. A description of outpatient drug use in rural China: evidence of differences due to insurance coverage. The International Journal of Health Planning and Management 1999, 14:41-56.
15. Albert A.O., Mustafa C.K., Charles O. Determinants of health expenditure growth of the OECD countries: Jackknife resampling plan estimates. Health Care Management Science 2004, 7:173-183.
16. Suh D.-C., Lacy C.R., Barone J.A., Moylan D., Kostis J.B. Factors contributing to trends in prescription drug expenditures. Clinical Therapeutics 1999, 21:1241-1253.
17. Hartwig J. What drives health care expenditure?-Baumol's model of 'unbalanced growth' revisited. Journal of Health Economics 2008, 27:603-623.
18. Nandakumar A.K., Farag M.E., Kris H. Determinants of national health expenditure. International encyclopedia of public health 2008, Academic Press, Oxford, pp. 136-145.
19. Shah N. Pharmaceutical supply chains: key issues and strategies for optimisation. Computers & Chemical Engineering 2004, 28:929-941.
20. Shao X., Ji J. Reconfiguration of pharmaceutical logistics operations in China: an empirical study. Transportation Journal 2006, 45:52-66.
21. Dong H., Bogg L., Rehnberg C., Diwan V. Drug policy in China: pharmaceutical distribution in rural areas. Social Science & Medicine 1999, 48:777-786.
22. Sun Q., Santoro M.A., Meng Q., Liu C., Eggleston K. Pharmaceutical policy In China. Health Affairs 2008, 27:1042-1050.
23. Measures on the administration of drug registration [in Chinese]. [accessed 01.15.09]. http://www.sda.gov.cn/WS01/CL0055/25427.html.
24. White Paper: Status Quo of Drug Supervision in China. [accessed 01.15.09]. http://english.gov.cn/2008-07/18/content_1049011.html.
25. Wang H. A dilemma of Chinese healthcare reform: how to re-define government roles?. China Economic Review 2009, 4:598-604.
26. Du D. Difficulties in pricing pharmaceutical. Price theory and practice 2002, 3:10-11. [in Chinese].
27. Meng Q., Cheng G., Silver L., Sun X., Rehnberg C., Tomson G. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals. Health Policy and Planning 2005, 20:185-196.
28. Xiao Y., Zheng D. Causes and countermeasures on high drug prices. Chinese Pharmaceutical Affairs 2008, 22:751-755. [in Chinese].
29. Zhong J. Influencing factors on medical quality and measures for management. Chinese Journal of Hospital Management 2001, 17:536-548. [in Chinese].
30. Sun X., Jackson S., Carmichael G.A., Sleigh A.C. Prescribing behaviour of village doctors under China's New Cooperative Medical Scheme. Social Science & Medicine 2009, 68:1775-1779.
31. China passes new medical reform plan [in Chinese]. [accessed 01.23.09]. http://news.xinhuanet.com/english/2009-01/21/content_10698501.html.
32. China issues draft of health reform plan. [accessed 01.12.08]. http://www.interfax.cn/news/6107/.
33. Greenberg P.E., Arcelus A., Birnbaum H.G., Cremieux P.Y., LeLorier J., Ouellette P., Slavin M.B. Pharmacoeconomics and health policy: current applications and prospects for the future. PharmacoEconomics 1999, 16:425-432.
34. Walley T., Haycox A. Pharmacoeconomics: basic concepts and terminology. British Journal of Clinical Pharmacology 1997, 43:343-348.